Czechia's population-wide cancer registry, run by the state health statistics institute ÚZIS. Its data summary for 2024 counts 102,027 new malignant cancers, 69,015 of them other than the common non-melanoma skin cancers.
The Národní onkologický registr is, in ÚZIS's own description, a population-wide registry that continues the monitoring of tumours in the Czech population introduced in the 1950s, and that ÚZIS has run as a population registry of individual tumour records since 1976. Every provider who diagnoses or treats a new tumour, and every pathology or cytology laboratory that confirms one, must report it under Act 372/2011 Coll. on health services and Decree 373/2016 Coll.; reports cover malignant tumours (C00 to C97), in situ and uncertain-behaviour tumours, and cancers first found at autopsy or on the death examination form. The registry is a member of the International Association of Cancer Registries and works with the European Network of Cancer Registries.
Its published data summaries are built from the registry's own reports, checked and completed against the national register of reimbursed health services, the national hospitalisation register and the death examination forms. The incidence summary processed on 24 June 2026 counts 102,027 malignant cancers diagnosed in 2024 (54,009 in men, 48,018 in women), of which 33,012 were non-melanoma skin cancers (C44); without them, 69,015, a world age-standardised rate of 299.9 per 100,000. The mortality summary, based on Czech Statistical Office death records corrected by the registry for selected diagnoses, counts 27,219 deaths from malignant cancers in 2024. The summaries also give the stage at diagnosis: 47.1% of lung cancers registered in 2024 were stage IV.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/